Ownership history in Ruffer LLP · 18 quarters on record
This page tracks every 13F SEC filing in which Ruffer LLP reported a position in Bristol Myers Squibb Co COM (BMY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 151,760 | +147,256 | +3269.4% | 0.38% | $6.8M | $43.97 |
| 2023 Q1 | REDUCED | 4,504 | -72,451 | -94.1% | 0.01% | $312K | $60.45 |
| 2022 Q4 | REDUCED | 76,955 | -262,276 | -77.3% | 0.37% | $5.6M | $62.26 |
| 2022 Q3 | REDUCED | 339,231 | -1,207,574 | -78.1% | 1.49% | $23.8M | $61.05 |
| 2022 Q2 | REDUCED | 1,546,805 | -1,761,973 | -53.3% | 4.69% | $119.2M | $66.13 |
| 2022 Q1 | REDUCED | 3,308,778 | -1,628,767 | -33.0% | 5.65% | $241.6M | $62.29 |
| 2021 Q4 | ADDED | 4,937,545 | +988,450 | +25.0% | 7.38% | $306.5M | $52.33 |
| 2021 Q3 | REDUCED | 3,949,095 | -300,178 | -7.1% | 7.40% | $234.0M | $49.66 |
| 2021 Q2 | ADDED | 4,249,273 | +52,417 | +1.2% | 7.95% | $283.9M | $55.22 |
| 2021 Q1 | ADDED | 4,196,856 | +2,327,044 | +124.5% | 8.11% | $265.0M | $52.17 |
As of 2025 Q4 — sorted by position size